James Whitcomb Riley Hospital for Children

Indianapolis, Indiana 46202-5225

0 studies enrolling now · 13 studies all time

What they study most

Anemia, Congenital Heart Disease, Cystic Fibrosis, Deep Vein Thrombosis, Immune Thrombocytopenia, Inflammatory Bowel Disease, Intrauterine Growth Retardation, Leukemia, Pediatric, Lung Infection, Malignant Melanoma, Minimal Hepatic Encephalopathy, Pseudomonas Aeruginosa

Studies at this site

• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• Age of Blood in Children in Pediatric Intensive Care Units — Completed
• ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP — Completed
• Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry — Completed
• Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures — Completed
• Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma — Stopped early
• Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease — Completed
• Study of Lactulose in Children With Chronic Liver Disease — Stopped early
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease — Completed
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa — Completed
• Phase II Study of Growth Hormone in Children With Cystic Fibrosis — Completed
• Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation — Status unconfirmed